We are live on ! Find out more
TCRR

TCR2 Therapeutics Inc. Common Stock
TCRR

Delisted

TCRR was delisted on the 31st of May, 2023.

Back to rankings

24 hedge funds and large institutions have $136M invested in TCR2 Therapeutics Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 24 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+24
Holders Change %
–
% of All Funds
0.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MAM
MPM Asset Management
Massachusetts
+$71.8M
2
RG
Redmile Group
California
+$32.1M
3
AG
Artal Group
Luxembourg
+$8.69M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$8.35M
5
HIM
Hillhouse Investment Management
Cayman Islands
+$5.73M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
1
MPM Asset Management
Massachusetts
$70.6M +$71.8M +4,050,865 New
RG
2
Redmile Group
California
$28.7M +$32.1M +1,807,256 New
AG
3
Artal Group
Luxembourg
$8.54M +$8.69M +490,000 New
ACH
4
ArrowMark Colorado Holdings
Colorado
$8.2M +$8.35M +470,698 New
HIM
5
Hillhouse Investment Management
Cayman Islands
$5.63M +$5.73M +322,903 New
Millennium Management
6
Millennium Management
New York
$4.19M +$4.27M +240,638 New
JP Morgan Chase
7
JP Morgan Chase
New York
$3.46M +$3.52M +198,721 New
Ameriprise
8
Ameriprise
Minnesota
$2.4M +$2.44M +137,796 New
Goldman Sachs
9
Goldman Sachs
New York
$984K +$1M +56,443 New
DIM
10
DC Investments Management
Virginia
$694K +$706K +39,814 New
Canada Pension Plan Investment Board
11
Canada Pension Plan Investment Board
Ontario, Canada
$523K +$532K +30,000 New
PPA
12
Parametric Portfolio Associates
Washington
$495K +$503K +28,372 New
BCM
13
BlueCrest Capital Management
Jersey
$458K +$466K +26,255 New
Norges Bank
14
Norges Bank
Norway
$436K +$443K +25,000 New
LCM
15
Laurion Capital Management
New York
$417K +$424K +23,900 New
OAM
16
Oxford Asset Management
United Kingdom
$301K +$307K +17,296 New
Victory Capital Management
17
Victory Capital Management
Texas
$192K +$195K +11,000 New
Bank of America
18
Bank of America
North Carolina
$41K +$41.7K +2,353 New
Barclays
19
Barclays
United Kingdom
$40K +$41.1K +2,318 New
Citigroup
20
Citigroup
New York
$39K +$39.8K +2,245 New
TRCT
21
Tower Research Capital (TRC)
New York
$19K +$19.2K +1,081 New
Morgan Stanley
22
Morgan Stanley
New York
$15K +$15.5K +872 New
CCA
23
Catalyst Capital Advisors
New York
$8K +$8.14K +459 New
UBS Group
24
UBS Group
Switzerland
$1K +$568 +32 New

TCRR Hedge Fund Activity: Q1 2019 in Review

24 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in TCR2 Therapeutics Inc. Common Stock (TCRR) for Q1 2019, worth a combined $136M.

Buyers outnumbered sellers: 24 funds opened new TCRR positions and 0 closed out — a net gain of 24 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was MPM Asset Management, opening a new position worth an estimated $71.8M.

  • 24 institutional investors held TCR2 Therapeutics Inc. Common Stock (TCRR) as of Q1 2019, up from 0 in Q4 2018.
  • Funds reported $136M of TCR2 Therapeutics Inc. Common Stock stock for Q1 2019.
  • 24 funds opened new TCR2 Therapeutics Inc. Common Stock positions in Q1 2019 and 0 closed out, a net change of +24 holders.
  • The largest TCR2 Therapeutics Inc. Common Stock buyer in Q1 2019 was MPM Asset Management, an estimated $71.8M added.

Based on aggregated 13F filings for Q1 2019.